A human trail of Saccaharum Officinalis L. wax alcohols(Policosanol) on improvement of blood cholesterol

Not Applicable

Recruiting

• Conditions: Endocrine, nutritional and metabolic diseases

• Registration Number: KCT0008540
• Lead Sponsor: Wonkwang University, Gwangju Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1) Men and women aged 19 ~ 75
2) LDL-cholesterol 140~189 mg/dL and total cholesterol ≥ 200 mg/d

Exclusion Criteria

1. a person who has taken lipid lowering agent study within 6 months before the screening test.
2. BMI < 18.5 kg/m^2 or, ≥ 35 kg/m^2
3. fasting glucose level ≥ 140 mg/dL
4. a person who is taking on diabetes medication or out of control hypertension(Systolic Blood Pressure ≥140 mmHg OR Diastolic Blood Pressure ≥100 mmHg)
5. Subjects who are sensitive to Saccaharum Officinalis L. wax alcohols(Policosanol)
6. have a Coagulation disorder or, taking anticoagulant, antithrombotic.
7. a person who has experience in antipsychotic medication within 3 months before the screening test.
8. history of alcoholism or substance abuse
9. Pregnant or lactating women
10. fertile women without proper contraceptives
11. Participation in other human study within 3 months before the screening test.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DL-cholesterol;Total cholesterol

Secondary Outcome Measures

Name	Time	Method
ipid metabolism index; Atherogenic index;Anthropometric index